Novartis Pharma AG: Sandoz completes acquisition of GSK's cephalosporin business, reinforcing leading global position in antibiotics

Sandoz gains rights to three established brands sold in more than 100 marketsTransaction, including leading global brand Zinnat, complements Sandoz leadership in generic penicillins with leading position

Related Keywords

Germany ,Australia ,Taiwan ,Japan ,United States ,India ,Hong Kong ,Kundl ,Tirol ,Austria ,Egypt ,China ,Macau ,Pakistan ,America ,Richard Jarvis ,Isabella Zinck ,Chris Lewis ,Samir Shah ,Thomas Hungerbuehler ,Sloan Simpson ,Richard Saynor ,Instagram ,Linkedin ,Twitter ,Novartis ,Exchange Commission ,Novartis Global Communications ,Facebook ,Fortum ,Sandoz Global Communications ,Sandoz Global ,Dharma ,Sandoz ,Ompletes ,Cquisition ,Cephalosporin ,Business ,Reinforcing ,Reading ,Lobal ,Position ,Antibiotics ,